Tracked deals
3
3 tracked deals across 2021-2026.
Operating Company
Software
InVita Healthcare Technologies
Baltimore, Maryland, United States
Develops specialized, highly configurable software for regulated healthcare and public-safety organizations, including blood & plasma centers, organ/tissue donation organizations, implant & explant lifecycle management, and DNA/forensic sample management, with built-in compliance safeguards.
- Focus Areas
- Blood & plasma management software, Forensic DNA and sample tracking, Implant & explant lifecycle management software
- Website
- invitahealth.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
2 addon · 1 buyout
InVita Healthcare Technologies Acquisition Volume by Year
Last 3 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
July 8, 2026
- Buyer
- InVita Healthcare Technologies, Novacap (backer of InVita)
- Target
- MAK-SYSTEM
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Type
- Buyout
InVita Healthcare Technologies, backed by Novacap, completed its acquisition of MAK-SYSTEM to expand end-to-end blood management software solutions worldwide. The combined platform is intended to create a more connected and intelligent blood management ecosystem across donor to patient, improving visibility, interoperability, efficiency, and compliance.
-
- Buyer
- InVita Healthcare Technologies, The Riverside Company
- Target
- BloodHub
- Industry
- Cloud & SaaS
- Location
- Maryland, United States
- Type
- Addon
InVita Healthcare Technologies, a portfolio company of The Riverside Company, has acquired BloodHub and folded it into InVita's Blood Management Division. Riverside made the investment as an add-on to its InVita platform to expand InVita's blood- and biologics-focused supply chain and laboratory software capabilities across North America.
-
May 18, 2021
- Buyer
- The Riverside Company, InVita Healthcare Technologies
- Target
- STACS DNA
- Industry
- Software
- Location
- Ontario, Canada
- Type
- Addon
The Riverside Company has invested in STACS DNA as an add-on to its InVita Healthcare Technologies platform; InVita (backed by Riverside) will integrate STACS DNA's sample-tracking and lab management software into its suite for complex medical environments. STACS DNA, headquartered in Ottawa, Ontario, provides forensic and healthcare sample-tracking solutions used by customers such as the FBI, RCMP and Merck to improve laboratory workflows, compliance and patient safety.
Related Acquisition Pages
Cloud & SaaS Buyers & Acquisitions
1 tracked deal by InVita Healthcare Technologies.
Healthcare Services Buyers & Acquisitions
1 tracked deal by InVita Healthcare Technologies.
Software Buyers & Acquisitions
1 tracked deal by InVita Healthcare Technologies.
Acquisitions in Maryland
2 tracked deals by InVita Healthcare Technologies.
Selling a company? Get in front of buyers like InVita Healthcare Technologies
Turn tracked acquisition activity into an outreach-ready buyer list.